Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to provide support for research to facilitate well planned clinical trials aimed at advancing the science of tobacco cessation among adolescents. Specifically, the FOA invites applications for Planning Grants (R34) to inform the planning, design, and initial development of adolescent tobacco cessation behavioral intervention studies, with an emphasis on the critical developmental risk period ranging from mid- to late adolescence (i.e., approximately 14-20 years old). Applications should propose clinical trial planning activities that are scientifically necessary to guide the design and conduct of a future clinical trial evaluating a tobacco cessation behavioral intervention for adolescents. Planning activities could include, but are not limited to, feasibility and pilot studies to assess intervention viability and/or trial design, and testing of recruitment, retention, and adherence strategies to increase participant engagement and scientific rigor.

Pre-Application Webinar for NCIs FOAs on Advancing Adolescent Tobacco Cessation Intervention Research (RFA-CA-22-042, RFA-CA-22-43) 
(NOT-CA-23-009) 
National Cancer Institute

November 8, 2022, from 1:00 PM to 2:00 PM Eastern Time